Bon Natural Life (BON) Short Interest Ratio & Short Volume

Short interest is the volume of Bon Natural Life shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 168,700 shares of BON short. 101.02% of Bon Natural Life's shares are currently sold short. Learn More on Bon Natural Life's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 101.02% of Bon Natural Life's floating shares are currently sold short.

Bon Natural Life saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 168,700 shares, an increase of 116.6% from the previous total of 77,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

101.02% of Bon Natural Life's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bon Natural Life: Trevena, Inc. (0.39%), Petros Pharmaceuticals, Inc. (4.60%), Revelation Biosciences, Inc. (8.41%), NuCana plc (48.60%), Viracta Therapeutics, Inc. (0.06%), Avenue Therapeutics, Inc. (2.76%), Hepion Pharmaceuticals, Inc. (0.21%), Syros Pharmaceuticals, Inc. (0.55%), Biophytis S.A. (0.53%), Kiromic BioPharma, Inc. (0.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling BON is an investing strategy that aims to generate trading profit from Bon Natural Life as its price is falling. BON shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bon Natural Life occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BON, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BON, twice per month. The most recent reporting period available is May, 31 2025.